Yes that number really scared away some short term holders and traders, and give Platinum every bits of reason to offload.
The positive data shows the drug works and can be a strong candidate in the area, however the Phase 3 trip is far away.
In the last 2 presentations Gary has somewhat downplayed the possibility of potential deal at the current Phase 2 stage, I really think he need to seriously consider it: the phase 3 like this without partner will cost 100s of million dollars.
But having said that, yesterday's positive data further de-risked 5505, we should see some steady share price rise (if not spike) from here.
Add to My Watchlist
What is My Watchlist?
